Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer
Author:
Publisher
Informa UK Limited
Subject
Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.3109/15569520903178208
Reference19 articles.
1. Epidemiology and Prevention of Pancreatic Cancer
2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
3. Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
4. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
5. Maculopapular eruption with enlarged macrophages in eight patients receiving G-CSF or GM-CSF
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Novel 12-Step Subcutaneous Desensitization Protocol to Pegfilgrastim;2024-06-04
2. Balancing Benefits and Risks: A Literature Review on Hypersensitivity Reactions to Human G-CSF (Granulocyte Colony-Stimulating Factor);International Journal of Molecular Sciences;2024-04-28
3. Delayed hypersensitivity reaction related to the use of pegfilgrastim;Journal of Oncology Pharmacy Practice;2014-07-03
4. Pyoderma gangrenosum: pathogenetic oriented treatment approaches;Wiener Medizinische Wochenschrift;2014-06-05
5. The prognostic role of the new entity butterfly-like facial rash and cutaneous findings in patients with crimean congo haemorrhagic fever;Journal of the European Academy of Dermatology and Venereology;2013-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3